WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007016385) USE OF SUBSTITUTED 5-AMINO-1H-PYRROLE-2-CARBONITRILE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/016385    International Application No.:    PCT/US2006/029509
Publication Date: 08.02.2007 International Filing Date: 27.07.2006
IPC:
A61K 31/40 (2006.01), A61K 31/4025 (2006.01), C07D 207/34 (2006.01), A61K 31/569 (2006.01), A61K 45/06 (2006.01), A61P 5/34 (2006.01), A61P 5/36 (2006.01), A61P 13/08 (2006.01), A61P 15/18 (2006.01), A61P 15/12 (2006.01), A61P 15/08 (2006.01), A61P 35/00 (2006.01)
Applicants: WYETH [US/US]; Five Giralda Farms, Madison, NJ 07940 (US) (For All Designated States Except US).
MCCOMAS, Casey, Cameron [US/US]; (US) (For US Only).
FENSOME, Andrew [GB/US]; (US) (For US Only).
MELENSKI, Edward, George [US/US]; (US) (For US Only)
Inventors: MCCOMAS, Casey, Cameron; (US).
FENSOME, Andrew; (US).
MELENSKI, Edward, George; (US)
Agent: KODROFF, Cathy, A.; HOWSON AND HOWSON, 501 OFFICE CENTER DRIVE, Suite 210, Fort Washington, PA 19034 (US)
Priority Data:
60/704,005 29.07.2005 US
Title (EN) USE OF SUBSTITUTED 5-AMINO-1H-PYRROLE-2-CARBONITRILE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS
(FR) UTILISATION DES MODULATEURS DU RECEPTEUR DE LA PROGESTERONE
Abstract: front page image
(EN)The use of compounds of formula (I), or a pharmaceutically acceptable salt thereof, (I) wherein R1, R2, R3, R4, R5, R6 and R7, are as defined herein, for contraception, hormone replacement therapy, synchronizing estrus, treating dysmenorrhea, treating dysfunctional uterine bleeding, treating uterine myometrial fibroids, treating endometriosis, treating benign prostatic hypertrophy, treating carcinomas and adenocarcinomas of the endometrium, ovary, breast, colon, prostate, pituitary, and meningioma, inducing amenorrhea, cycle-related symptoms, or treating symptoms of premenstrual syndrome and premenstrual dysphoric disorder are described. Also provided are products containing these compounds.
(FR)L'invention porte sur l'utilisation de composés de formule (I) ou d'un sel de ceux-ci acceptable d'un point de vue pharmaceutique, formule dans laquelle R1, R2, R3, R4, R5, R6 et R7 sont tels que définis dans la demande, ces composés étant utiles dans la contraception, dans le traitement hormonal substitutif, la synchronisation de l'oestrus, le traitement de la dysménorrhée, le traitement de la ménométrorragie, le traitement des fibromes utérins, le traitement de l'endométriose, le traitement de l'hypertrophie bénigne de la prostate, le traitement des carcinomes et des adénocarcinomes de l'endométrium, des ovaires, du sein, du côlon, de la prostate, de l'hypophyse et du méningiome, induisant l'aménorrhée, les symptômes liés au cycle ou le traitement des symptômes du syndrome prémenstruel et du trouble dysphorique prémenstruel. L'invention porte également sur des produits contenant ces composés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)